Matt Smith

Principal at VS Health Group

Speaker

Matt Smith is a biotech executive and consultant with 20 years of experience in oncology and infectious disease, specializing in commercial strategy, product launches, and market access. He is currently a Principal at VS Health Group, where he advises biotech and pharma clients on Inflation Reduction Act (IRA), 340B, and market access strategy. Previously, he was VP of Commercial Strategy and Global Market Access at Kronos Bio, and VP/Head of Market Access at Oncopeptides, leading the U.S. launch of Pepaxto. Earlier roles include Dynavax, XOMA, Medivation, and Genentech. Matt holds an MBA from the University of San Francisco and a BA from Connecticut College.